» Articles » PMID: 20441798

Nicotine Replacement in Abstinent Smokers Improves Cognitive Withdrawal Symptoms with Modulation of Resting Brain Network Dynamics

Overview
Journal Neuroimage
Specialty Radiology
Date 2010 May 6
PMID 20441798
Citations 108
Authors
Affiliations
Soon will be listed here.
Abstract

Symptoms of cognitive impairment during smoking withdrawal can be ameliorated by nicotine replacement. To define brain mechanisms contributing to this therapeutic effect, we conducted a functional connectivity analysis of resting-state fMRI in 17 abstinent smokers following nicotine replacement in a double-blind, placebo-controlled, crossover design. We found that individual differences in cognitive withdrawal symptom improvements after nicotine replacement were associated with increased inverse coupling between executive control and default mode brain networks. Furthermore, improvements in withdrawal symptoms were negatively correlated with altered functional connectivity within the default mode network, and with connectivity between the executive control network and regions implicated in reward processing. These findings demonstrate that nicotine administration in abstinent smokers modulates dynamic interactions between large-scale cognitive brain networks in the resting state. We specifically highlight the role of midline and prefrontal network regions in the neurocognitive response to nicotine pharmacotherapy and suggest that altered functional connectivity patterns of these networks reflect their engagement in reward and salience processing during smoking withdrawal. Individual differences in resting brain functional connectivity may predict therapeutic outcomes in nicotine addiction and other conditions associated with cognitive impairments.

Citing Articles

Altered executive control network and default model network topology are linked to acute electronic cigarette use: A resting-state fNIRS study.

Huang X, Qi Y, Zhang R, Pu Y, Chen X, Chen S Addict Biol. 2024; 29(7):e13423.

PMID: 38949205 PMC: 11215790. DOI: 10.1111/adb.13423.


Targeting GLP-1 receptors to reduce nicotine use disorder: Preclinical and clinical evidence.

Herman R, Schmidt H Physiol Behav. 2024; 281:114565.

PMID: 38663460 PMC: 11128349. DOI: 10.1016/j.physbeh.2024.114565.


Changes in distinct brain systems identified with fMRI during smoking cessation treatment with varenicline: a review.

Panagopoulos V, Bailey A, Kostopoulos G, Ioannides A Psychopharmacology (Berl). 2024; 241(4):653-685.

PMID: 38430396 PMC: 10927841. DOI: 10.1007/s00213-024-06556-2.


Accelerated aging in people living with HIV: The neuroimmune feedback model.

Schrock J Brain Behav Immun Health. 2024; 36:100737.

PMID: 38356933 PMC: 10864877. DOI: 10.1016/j.bbih.2024.100737.


Negative affect and craving during abstinence from smoking are both linked to default mode network connectivity.

Tabibnia G, Ghahremani D, Pochon J, Diaz M, London E Drug Alcohol Depend. 2023; 249:109919.

PMID: 37270935 PMC: 10516582. DOI: 10.1016/j.drugalcdep.2023.109919.